- Home
- Applications
- north america
- cancer awareness month patient
Show results for
Refine by
Cancer Awareness Month Patient Product Applications In North America
13 applications found
SNAQ-SEQ ctDNA spike-in standards Liquid biopsies offer the promise of earlier detection and monitoring of cancer patients’ treatment progression. However, as applications increasingly rely on ultra low variant allele frequency detection, NGS-based assays are beset with significantly more noise below 0.5% VAF that increases the rate of false positives. Laboratories looking to implement ctDNA assays need better quality controls that can ensure accurate detection and reporting by variant calling ...
ByAccuGenomics, Inc. based in Wilmington, NORTH CAROLINA (USA)
Data from examining the immune repertoire of cancer patients can be used to identify patterns associated with positive outcomes and monitor the progress of immunotherapies in clinical trials. Single cell immune sequencing technologies provide an even more granular view of individual T cell or B cell populations following immunotherapy, providing unprecedented detail for informing cancer ...
ByiRepertoire, Inc. based in Huntsville, ALABAMA (USA)
Data from examining the immune repertoire of cancer patients can be used to identify patterns associated with positive outcomes and monitor the progress of immunotherapies in clinical trials. Single cell immune sequencing technologies provide an even more granular view of individual T cell or B cell populations following immunotherapy, providing unprecedented detail for informing cancer ...
ByiRepertoire, Inc. based in Huntsville, ALABAMA (USA)
MarginProbe is an FDA-approved breakthrough in lumpectomy surgery that helps surgeons achieve optimum results during their procedures. A non-invasive medical device, MarginProbe examines excised tissue during lumpectomy surgery and can detect the presence or absence of cancer cells on the margins. This provides vital, real time information to surgeons when it matters ...
ByDilon Technologies Inc. based in Newport News, VIRGINIA (USA)
The reputation of your cancer treatment facility hinges on your ability to recruit world-class oncologists. Those who can collaborate to leverage pioneering technologies and therapies for the benefit of their patients. It’s an investment in talent and technology. And your technology must be proven, precise and ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
You likely already know that electron-beam IORT has been successfully treating multiple cancer indications for nearly 50 years and has been treating breast cancer since the early 1990’s. The first accelerated partial breast irradiation (APBI) treatment with the IntraOp® Mobetron® was performed in 2006. Today, more than 20,000 women have been treated with electron IORT demonstrating equivalency in local control with reduced toxicity and improved cosmesis. More than 10,000 breast cancer patients have ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
Comfortable and Efficient Compression Therapy Solutions . Lymphedema is swelling caused by a build-up of lymph fluid in the body. Lymph nodes are found throughout the body. Unfortunately, the lymph nodes near the breast can sometimes be affected by breast cancer treatment and cause the patient to develop lymphedema. Breast Cancer Related Lymphedema is usually related to axillary lymph node surgery and radiation therapy, but doctors and researchers still aren’t sure why some people get lymphedema and others ...
ByAIROS Medical Inc based in Audubon, PENNSYLVANIA (USA)
Gastric cancer is a disease in which cancer cells form in the lining of the stomach. Almost all gastric cancers are adenocarcinomas, a cancer that begins in glandular tissue. Gastric cancer is often in an advanced stage when it is diagnosed. At this stage, it can often be treated, but rarely ...
ByAscelia Pharma AB based in Malmö, SWEDEN
To date, the classification of cancers has been based solely on the phenotypic and genotypic characteristics of tumor cells. A new paradigm, scientifically well established and recommended by WHO guidelines, relies on the introduction of the immune response as a new prognostic parameter to predict and refine the clinical outcomes of cancer patients. Maximize patient survival rates with an assessment of the tumor immune response. ...
ByVeracyte based in Marseille Cedex 9, FRANCE
Mohs surgery has long provided the traditional path to effective treatment for skin cancer. Yet for many patients, surgery may not be most desirable due to medical contraindications, their active lifestyle, and/or potential cosmetic concerns. For those patients, there is now a convenient, non-invasive option: electron therapy for skin cancer from ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
Advances in diagnostic methods have enabled the detection of cancer at the earliest stages when the chances for successful intervention are highest. For many solid tumors, the best chance for a cure is surgery. A surgical cure depends upon the complete removal of all cancer tissue from a patient (a “complete resection”). The main challenge of this approach is that it is very difficult for a surgeon to determine where diseased tissue ends and healthy tissue begins. The result is that many surgical ...
ByAkrotome Imaging, Inc. based in Cleveland, OHIO (USA)
Surgery isn’t an option for every patient diagnosed with pancreatic cancer. But with the IntraOp® Mobetron® and electron IORT, more patients than ever before are eligible. And we know that those who are treated surgically have a higher chance of ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
A liquid biopsy from Biocept gives you a new tool for profiling breast cancer—with a simple blood ...
ByBiocept based in San Diego, CALIFORNIA (USA)